A number of recent studies suggests that shingles vaccine has benefits beyond just protecting against shingles. A new study ...

Last April, Brad reported on the discovery that the shingles vaccine reduced dementia risk. In May, he reported on research ...

A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against ...

Every three seconds, someone, somewhere in the world, develops dementia. The number of people living with the condition is projected to rise dramatically, doubling from 78 million in 2020 to 139 ...

Research has found that a routine vaccine slows aging and cuts dementia risk.

Vaccination is associated with a 23% lower risk of experiencing a potentially deadly cardiac problem.

Many public-health authorities recommend the shingles vaccine for people between 65 and 80 (although the range varies by region). The sharp age cut-offs used in the roll-out in each country or region, ...

The varicella-zoster virus causes both chickenpox and shingles infections. Initially, the virus causes a chickenpox infection. If it reactivates later, shingles can develop. The chickenpox vaccine ...

By Hugo Francisco de Souza New real-world evidence links shingles vaccination with reduced dementia risk, raising important questions about viral triggers, inflammation, and future prevention ...

The shingles vaccine not only offers protection against the painful viral infection, a new study suggests that the two-dose shot also may slow the progression of dementia. Shingles, caused by the ...

Research from Canada shows that people vaccinated against shingles have a lower dementia risk. There may be a catch, however.